MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Home・Aandelen Lijst・Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings Inc (Class A)

Gesloten

SectorGezondheidszorg

3.38 -0.29

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.34

Max

3.38

Belangrijke statistieken
By Trading Economics
Inkomsten	-15M -40M
Verkoop	8.2M 50M
Winstmarge	-80.43
Werknemers	435
EBITDA	-19M -42M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+17.99% upside

Dividenden
By Dow Jones
Volgende Winsten	11 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	4.2M 1.1B
Vorige openingsprijs	3.67
Vorige sluitingsprijs	3.38

Nieuwssentiment

By Acuity

50%

135 / 348 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

2.02 / 2.115 Steun & Weerstand

Maravai LifeSciences Holdings Inc (Class A) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 apr 2026, 23:48 UTC

Belangrijke Nieuwsgebeurtenissen

Crude Oil, Refined Product Prices Moving Higher Amid Renewed Tensions in Strait of Hormuz -- OPIS

19 apr 2026, 23:36 UTC

Belangrijke Nieuwsgebeurtenissen

NAB Raises Provisions as Australian Banks Face Iran Risks -- Update

19 apr 2026, 22:47 UTC

Belangrijke Nieuwsgebeurtenissen

National Australia Bank Adds $215 Million in Iran-Driven Credit Provisions

19 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

19 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

19 apr 2026, 23:49 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold, Silver Decline Amid Renewed Inflation Concerns -- Market Talk

19 apr 2026, 23:46 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

19 apr 2026, 23:38 UTC

Belangrijke Nieuwsgebeurtenissen

U.A.E. Asks U.S. About a Wartime Financial Lifeline -- Update

19 apr 2026, 23:36 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Climbs on Renewed Tensions Over Strait of Hormuz -- Market Talk

19 apr 2026, 23:12 UTC

Belangrijke Nieuwsgebeurtenissen

Spot Gold Falls 1.2%, Spot Silver Drops 1.6% on Renewed Middle East Tensions

19 apr 2026, 23:10 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month Brent Crude Oil Futures Rise 5.8% to $95.64 per Barrel

19 apr 2026, 23:09 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Crude Oil Futures Climb 7.2% to $89.86 per Barrel

19 apr 2026, 23:08 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month Crude Oil Futures Climb on Renewed Tensions Over Strait of Hormuz

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Eli Lilly Nears Deal for Cancer Biotech -- WSJ

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Announcement Could Come As Soon As Monday, Sources Say -- WSJ

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Deal Expected to Be Worth Over $2B Plus Additional Milestones, Sources Say -- WSJ

19 apr 2026, 21:20 UTC

Acquisities, Fusies, Overnames

Eli Lilly Nears Deal for Kelonia Therapeutics, Sources Say -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

U.A.E. Central Bank Governor Khaled Mohamed Balama Raised Swap Idea With Treasury Secretary Scott Bessent in Washington -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

Emiratis Portrayed Swap Proposal as Precautionary and Preliminary in Case Iran War Drags On -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

The U.A.E. Has Opened Talks with U.S. for Currency Swap -- WSJ

19 apr 2026, 20:03 UTC

Belangrijke Nieuwsgebeurtenissen

U.A.E. Asks U.S. for a Wartime Financial Lifeline -- WSJ

18 apr 2026, 01:00 UTC

Belangrijke Nieuwsgebeurtenissen

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 apr 2026, 22:58 UTC

Winsten

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr 2026, 21:32 UTC

Marktinformatie

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr 2026, 20:52 UTC

Winsten

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr 2026, 20:50 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

17 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 apr 2026, 20:29 UTC

Winsten

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

Peer Vergelijking

Prijswijziging

Maravai LifeSciences Holdings Inc (Class A) Prognose

Koersdoel

By TipRanks

17.99% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4 USD 17.99%

Hoogste 5 USD

Laagste 3 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Maravai LifeSciences Holdings Inc (Class A) - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

Buy

Hold

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Maravai LifeSciences Holdings Inc (Class A) - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

2.02 / 2.115Steun & Weerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Sentiment

By Acuity

135 / 348 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.